Synergistic effects of COVID-19 and Pseudomonas aeruginosa in chronic obstructive pulmonary disease: a polymicrobial perspective

SK Bajire, RP Shastry - Molecular and Cellular Biochemistry, 2024 - Springer
This article discusses the connection between the novel coronavirus disease 2019 (COVID-
19) caused by the coronavirus-2 (SARS-CoV-2) and chronic obstructive pulmonary disease …

TGF Beta as a Prognostic Biomarker of COVID-19 Severity in Patients with NAFLD—A Prospective Case–Control Study

F Susak, N Vrsaljko, A Vince, N Papic - Microorganisms, 2023 - mdpi.com
Non-alcoholic fatty liver disease (NAFLD), the leading cause of chronic liver disease in
Western countries, has been identified as a possible risk factor for COVID-19 severity …

Organ-Dysfunction Markers in Mild-to-Moderate COVID-19 Convalescents

A Wiśniewska, A Kijak, K Nowak, M Lulek… - Journal of Clinical …, 2024 - mdpi.com
Background: A coronavirus disease 2019 (COVID-19) outbreak led to a worldwide
pandemic. COVID-19 not only caused acute symptoms during the severe phase of the …

A Specific Pattern and Dynamics of Circulating Cytokines Are Associated with the Extension of Lung Injury and Mortality in Colombian Adults with Coronavirus …

S Bolívar-Marín, M Castro… - Journal of Interferon & …, 2023 - liebertpub.com
Increased systemic levels of inflammatory cytokines have been associated with the
development of pathophysiologic events during severe acute respiratory syndrome …

Correlation between IL-17, TGF-β and PTPN-22 Levels and Covid-19 Severity in Patients with and without Autoimmune Diseases

MA Hassan, MN Agban, AA Elkhawaga - Egyptian Journal of …, 2024 - journals.ekb.eg
Background: The Coronavirus pandemic is the most significant global health crisis of our
era. Since it first appeared in late 2019, the virus has spread to every continent. Furthermore …

Utjecaj nealkoholne masne bolesti jetre na serumske koncentracije transformirajućeg čimbenika rasta beta u COVID-19

F Šušak - 2023 - zir.nsk.hr
Sažetak Nealkoholna masna bolest jetre (NAFLD) vodeći je uzrok kronične jetrene bolesti u
razvijenom svijetu i prepoznata je kao rizični faktor za razvoj težih oblika COVID-19. Unatoč …